Follow
Francesco Staehli, PhD
Francesco Staehli, PhD
Debiopharm International SA
Verified email at global.educanet2.ch - Homepage
Title
Cited by
Cited by
Year
Type I interferon inhibits interleukin-1 production and inflammasome activation
G Guarda, M Braun, F Staehli, A Tardivel, C Mattmann, I Förster, M Farlik, ...
Immunity 34 (2), 213-223, 2011
10322011
T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes
G Guarda, C Dostert, F Staehli, K Cabalzar, R Castillo, A Tardivel, ...
Nature 460 (7252), 269-273, 2009
2892009
NLRC5 deficiency selectively impairs MHC class I-dependent lymphocyte killing by cytotoxic T cells
F Staehli, K Ludigs, LX Heinz, Q Seguin-Estevez, I Ferrero, M Braun, ...
The Journal of Immunology 188 (8), 3820-3828, 2012
1702012
NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions
K Ludigs, C Jandus, DT Utzschneider, F Staehli, S Bessoles, AT Dang, ...
Nature communications 7 (1), 10554, 2016
482016
The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade
LX Heinz, M Rebsamen, DC Rossi, F Staehli, K Schroder, M Quadroni, ...
Cell Death & Differentiation 19 (4), 722-731, 2012
322012
NLRC5 deficiency impairs MHC class I-dependent lymphocyte killing by cytotoxic T cells
G Guarda, F Staehli, K Ludigs, L Heinz, Q Seguin-Estevez, I Ferrero, ...
Immunology 137 (Suppl. 1), 17-17, 2012
2012
Immune regulation and function of the NOD-like receptors NLRC5 and NLRP3
F Staehli
Université de Lausanne, Faculté de biologie et médecine, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–7